Delivery Order SPE2DB20D3103-SPE2DB23FM4G6
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of Etonogestrel-EE vaginal rings. The $3,634.50 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,307.12 delivery order contract is for the procurement of ETONOGESTREL-EE VAGINAL RINGS, a type of pharmaceutical product. The contract is a firm fixed-price, delivery order contract with a period of performance through May 1, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) for the supply of Etonogestrel-EE Vaginal Rings. The award, valued at $2,137.38, was made by the Defense Logistics Agency (DLA) on September 10, 2021, with a completion date of September 13, 2021. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Etonogestrel-EE vaginal rings. The delivery order, valued at $3,811.62, has a completion date of December 17, 2021. The contract is a firm fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,119.71 for the supply of ETONOGESTREL-EE VAGINAL RINGS. The award was made by the Defense Logistics Agency (DLA), a defense agency, on August 23, 2021, with a completion date of August 24, 2021. The contract is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award is for the delivery of Etonogestrel-EE vaginal rings to the Defense Logistics Agency (DLA). The $3,548.90 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of January 11, 2024. This delivery order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,453.92 firm-fixed-price delivery order is for the provision of Etonogestrel-EE vaginal rings. The contract has a period of performance through July 20, 2023 and does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The federal contract award, valued at $1,956.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Etonogestrel-EE Vaginal Rings, a medical commodity used in various healthcare applications. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $2,527.20, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,423.20 firm fixed-price delivery order is for the supply of Etonogestrel-EE Vaginal Rings, a contraceptive product. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM4G6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific Delivery Order, valued at $5,373.47, is for the procurement of Etonogestrel-EE Vaginal Rings. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen, as a major pharmaceutical distributor, has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company's extensive supply chain and distribution capabilities enable it to efficiently fulfill government contracts for essential medical commodities across various therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 2/9/23 |